Clinical decision support tool predicts risk of infection in patients with inflammatory bowel disease treated with vedolizumab

Parambir Dulai  1     Ding Feng  2     Karen Lasch  2    
1 University of California San Diego,La Jolla,United States
2 Takeda Pharmaceuticals USA Inc,Deerfield,United States

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing